New Genetic Technique May Provide a One-Time Cure for High Cholesterol
Scientists have achieved a major breakthrough that could change how the world treats high cholesterol. Based on the news on pafikutaikab.org Using an advanced form of gene editing, researchers have developed a one-time treatment that may permanently lower cholesterol levels potentially replacing the need for lifelong medication such as statins.
The study, recently published in Nature, was conducted by an international team of scientists from the United States and the United Kingdom. The researchers used a new gene-editing technology designed to “switch off” a specific gene in the liver responsible for producing a protein known as PCSK9. This protein plays a central role in regulating cholesterol levels in the bloodstream.
Dr. Laura Bennett, a genetic researcher involved in the project, explained that by inactivating the PCSK9 gene, the liver becomes more efficient at removing LDL cholesterol — commonly known as “bad cholesterol” — from the blood. “This approach represents a long-term and potentially permanent solution for patients with dangerously high cholesterol levels,” she said.
The therapy uses a precise form of genetic modification similar to CRISPR, but with improved accuracy and safety. Instead of cutting DNA strands directly, the new method makes targeted changes to deactivate genes without causing harmful mutations. The team used a single injection containing nanoparticles that deliver the gene-editing tool directly to the liver cells.
Early animal trials have shown promising results. In monkeys, a single dose reduced LDL cholesterol by up to 60 percent within weeks, and the effect lasted for more than a year with no major side effects observed. Researchers believe that in humans, this could translate to a permanent reduction in cholesterol after just one treatment.
High cholesterol is one of the leading risk factors for heart disease, stroke, and atherosclerosis, conditions that claim millions of lives each year. While statins and other medications are effective, they require daily use and can sometimes cause side effects such as muscle pain or liver issues. A one-time genetic solution could revolutionize preventive medicine by offering patients lifelong protection without ongoing treatment.
However, experts caution that more testing is needed before the technique can be safely applied to humans. Clinical trials are expected to begin within the next two years. “While the results are exciting, we must ensure the treatment is safe, effective, and ethically sound,” said Dr. Bennett.
Ethical concerns remain a central topic in the discussion of gene editing. Scientists emphasize that this approach does not alter DNA in reproductive cells — meaning it will not be passed to future generations — but public trust will depend on transparent research and strict regulation.
Cardiologists and geneticists around the world are optimistic about the discovery. If successful in human trials, the therapy could drastically reduce the global burden of cardiovascular disease. It may also pave the way for other genetic treatments targeting metabolic disorders, diabetes, or obesity.
For now, researchers see the development as an important step toward a future where chronic diseases can be treated — or even cured — at the genetic level. As Dr. Bennett concluded, “We are not just treating high cholesterol anymore. We’re addressing the root cause written in our DNA and that could redefine medicine for generations to come.”
Source: https://pafikutaikab.org/